CKD-498

· Chong Kun Dang Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CKD-498, covering 2024-06-28 to 2024-06-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia [Phase 2]

See pricing